XM does not provide services to residents of the United States of America.
A
A

Amphenol


News

U.S. STOCKS Walgreens, Copper miners, Simon Property

BUZZ-U.S. STOCKS ON THE MOVE-Walgreens, Copper miners, Simon Property Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell over 1% as investors assessed latest factory activity data, with a slew of labor market reports due through the week that could influence the extent of monetary policy easing by the Federal Reserve this year.
B
C
C
G
N
R
T
W
U
R
U
U
S
X
A
I
M
M
R

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Molson Coors Beverage Co TAP.N +6.1% Dexcom Inc DXCM.OQ +4.3% SBA Communications Corp SBAC.OQ +3.0% Church & Dwight Co Inc CHD.N +3.0% Southwest Airlines Co LUV.N +3.0% Bottom Performers Percent Change Vistra Corp VST.N -9.2% Boeing Co
B
N
K
U
D
A
C
M

U.S. Apple, Centerpoint Energy, Cummins

U.S. RESEARCH ROUNDUP-Apple, Centerpoint Energy, Cummins Aug 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Apple, Centerpoint Energy and Cummins, on Friday. HIGHLIGHTS * Apple Inc AAPL.O : Wedbush raises target price to $285 from $275 * Centerpoint Energy CNP.N : JP Morgan cuts to neutral from overweight * Cummins CMI.N : Jefferies raises target price to $365 from $345 * Motorola MSI.N : JP Morgan raises target pr
A
A
B
B
I
K
M
A
B
C
A
A
A
A
C
C
L
M

U.S. Edwards Lifesciences, National Bank Holdings, Sage Therapeutics

U.S. RESEARCH ROUNDUP-Edwards Lifesciences, National Bank Holdings, Sage Therapeutics July 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Edwards Lifesciences, National Bank Holdings and Sage Therapeutics, on Thursday. HIGHLIGHTS * Edwards Lifesciences Corp EW.N : JP Morgan cuts to neutral from overweight * National Bank Holdings Corp NBHC.N : Piper Sandler cuts to neutral from overweight * Sage Therapeutics Inc S
A
A
C
C
G
S
C
E
H
I
A
A
E
L

Amphenol sees third-quarter revenue below estimates on weak equipment demand

UPDATE 1-Amphenol sees third-quarter revenue below estimates on weak equipment demand Rewrites throughout July 24 (Reuters) - Electronic equipment maker Amphenol APH.N forecast third-quarter revenue below market estimates on Wednesday, as customers across broadband and industrial markets scale back on spending in the face of high borrowing costs. Shares of the Wallingford, Connecticut-based company fell 4.2% in early trading.
A

Amphenol beats Q2 revenue on steady demand for defense, communication equipment

Amphenol beats Q2 revenue on steady demand for defense, communication equipment July 24 (Reuters) - Electronic equipment maker Amphenol APH.N beat market estimates for second-quarter sales on Wednesday, on the back of growing demand for defense and communication equipment. Amid the dynamic geopolitical environment, countries across the globe are expanding their investments in next-generation defense technologies.
A

Amphenol Q2 Sales USD 3,609.7 Million Vs. IBES Estimate USD 3,390 Million

BRIEF-Amphenol Q2 Sales USD 3,609.7 Million Vs. IBES Estimate USD 3,390 Million Jul 24 (Reuters) - Amphenol Q2 operating income USD 698.8 million. Q2 gross profit USD 1,213.1 million Q2 net income USD 528.7 million Q2 EPS USD 0.41 Q2 adjusted EPS USD 0.44 outlook Q3 adjusted EPS USD 0.43-0.45 outlook Q3 revenue USD 3,700-3,800 million
A

U.S. Colgate-Palmolive, McKesson, Microsoft

U.S. RESEARCH ROUNDUP-Colgate-Palmolive, McKesson, Microsoft July 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Colgate-Palmolive, McKesson and Microsoft, on Tuesday. HIGHLIGHTS * Colgate-Palmolive Co CL.N : TD Cowen initiates coverage with buy rating; PT $110 * DR Horton Inc DHI.N : JP Morgan raises target price to $180 from $163 * IQVIA Holdings Inc IQV.N : Baird raises target price to $251 from $235 * McKesso
C
H
M
M
T
V
Z
F
A
M
A
C
C
D
I

Amphenol Corp <APH.N> expected to post earnings of 41 cents a share - Earnings Preview

Amphenol Corp expected to post earnings of 41 cents a share - Earnings Preview Amphenol Corp APH.N , APH is expected to show a rise in quarterly revenue when it reports results on July 24 for the period ending June 30 2024 The Wallingford Connecticut-based company is expected to report a 10.8% increase in revenue to $3.384 billion from $3.05 billion a year ago, according to the mean estimate from 14 analysts, based on LSEG data.The company's guidance on April 24 2024, for the period ended June
A

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Attica Bank, Kuvimba Mining House, Leonardo, Asterion; updates Meta Platforms July 18 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1 930 GMT on Thursday: * * Attica Bank BOAr.AT , Greece's fifth largest lender, announced that it had finalised a deal to merge with the smaller Pancretan Bank in an effort to clean up its balance sheet and create a new banking organisation.
F
R
A
D

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Meta, CommScope, Clayton, Dubilier & Rice, Schenker July 18 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday: ** Meta Platforms META.O has explored a multibillion-euro investment in eyewear group EssilorLuxottica ESLX.PA , the Financial Times reported.
F
A
D

Amphenol Corporation To Acquire Mobile Networks Businesses From Commscope

BRIEF-Amphenol Corporation To Acquire Mobile Networks Businesses From Commscope July 18 (Reuters) - Amphenol Corp APH.N : AMPHENOL CORPORATION TO ACQUIRE MOBILE NETWORKS BUSINESSES FROM COMMSCOPE AMPHENOL CORP - DEAL EXPECTED TO BE ACCRETIVE TO AMPHENOL'S DILUTED EPS IN FIRST FULL YEAR AFTER CLOSING AMPHENOL CORP - EXPECTS TO FINANCE ACQUISITION TH
A

CommScope jumps after $2.1 bln deal to sell two business units

BUZZ-CommScope jumps after $2.1 bln deal to sell two business units ** CommScope Holding COMM.O shares jump 58% to $2.70 premarket ** The communication infrastructure firm is selling its outdoor wireless and antenna systems units to Amphenol Corp APH.N for $2.1 bln in cash ** APH shares up 1.5% to $65.20 premarket ** Sale is expected to close in th
A

CommScope to sell some business units to Amphenol for $2.1 bln

UPDATE 2-CommScope to sell some business units to Amphenol for $2.1 bln Updates shares, adds details and background in paragraphs 3-5, 7,8,11 July 18 (Reuters) - CommScope COMM.O will sell its outdoor wireless network and its distributed antenna systems businesses to Amphenol APH.N for $2.1 billion in cash, the U.S. network infrastructure provider said on Thursday.
G
A

CommScope to sell wireless network and antenna system to Amphenol for $2.1 bln

CommScope to sell wireless network and antenna system to Amphenol for $2.1 bln July 18 (Reuters) - CommScope COMM.O said on Thursday it was selling its outdoor wireless network segment and its distributed antenna systems business to Amphenol APH.N for $2.1 billion in cash. Reporting by Zaheer Kachwala in Bengaluru; Editing by Shilpi Majumdar
A

CommScope to Sell its Outdoor Wireless Networks and Distributed Antenna Systems Businesses to Amphenol Corporation

BRIEF-CommScope to Sell its Outdoor Wireless Networks and Distributed Antenna Systems Businesses to Amphenol Corporation July 18 (Reuters) - CommScope Holding Company Inc COMM.O : COMMSCOPE TO SELL ITS OUTDOOR WIRELESS NETWORKS AND DISTRIBUTED ANTENNA SYSTEMS BUSINESSES TO AMPHENOL CORPORATION COMMSCOPE HOLDING COMPANY INC - COMMSCOPE WILL RECEIVE APPROXIMATELY USD $2.1 BILLION IN CASH, TO BE PAID BY AMPHENOL UPON CLOSING.
A

US court's reversal of 'Chevron deference' may limit investments in EVs, safer chemicals, Jefferies says

US court's reversal of 'Chevron deference' may limit investments in EVs, safer chemicals, Jefferies says July 11 (Reuters) - The U.S. Supreme Court's recent decision to overturn a 1984 precedent, which allowed government agencies to interpret unclear laws, could curb investments in electric vehicles and the development of safer chemicals used in manufacturing, according to a Jefferies analyst.
C
X
A
T

U.S. Nvidia, Qualcomm, Tesla

U.S. RESEARCH ROUNDUP-Nvidia, Qualcomm, Tesla July 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Nvidia, Qualcomm and Tesla, on Wednesday. HIGHLIGHTS * Brighthouse Financial Inc BHF.O : Jefferies raises to buy from hold * Legalzoom.Com Inc LZ.O : JP Morgan cuts to neutral from overweight * Nvidia Corp NVDA.O : KeyBanc raises target price to $180 * Qualcomm Inc QCOM.O : KeyBanc raises target price to $225 * Tesla
A
A
A
A
A
C
G
M
M
N
P
Q
S
T
A
A
A
C
O
B
T
A
A
A
A
C
G
L
U

U.S. Ardelyx, Eli Lilly, Tesla

U.S. RESEARCH ROUNDUP-Ardelyx, Eli Lilly, Tesla July 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ardelyx, Eli Lilly and Tesla, on Wednesday. HIGHLIGHTS * Ardelyx Inc ARDX.O : Piper Sandler cuts to neutral from overweight * Eli Lilly LLY.N : Jefferies raises target price to $1,041 from $1,015 * Nicolet Bankshares Inc NIC.N : Stephens raises target price to $90 from $88 * Tesla Inc TSLA.O : Wedbush raises target
A
C
C
C
H
I
J
M
T
C
F
D
A
C
M



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.